Literature DB >> 1120290

Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat.

P H Wu, A A Boulton.   

Abstract

In the absence of a monoamine oxidase inhibitor, the bulk of intravenously injected radioactively labelled beta-phenylethylamine was oxidized to phenylacetic acid. In the presence of pargyline, most of the label in tissues remained as unchanged phenylethylamine; small amounts of labelled phenylethanolamine, tyramine and octopamine were also identified. After intravenous injection of [14-C]phenylalanine, only very small amounts of [14-C] phenylethylamine could be located in urine and faeces. Beta-Phenylethylamine became concentrated in all tissues, including brain, following intravenous introduction both in the presence and absence of pargyline. Its clearance from these tissues and from brain regions was very fast.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120290     DOI: 10.1139/o75-007

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  16 in total

Review 1.  The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity.

Authors:  Gregory M Miller
Journal:  J Neurochem       Date:  2011-01       Impact factor: 5.372

2.  An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.

Authors:  O E Ukponmwan; J Rupreht; M Dzoljic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

3.  Environmental experience produces qualitative changes in the stimulant effects of beta-phenylethylamine in rats.

Authors:  C T Dourish; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

4.  Effects of tranylcypromine on the concentration of some trace amines in the diencephalon and hippocampus of the rat.

Authors:  S R Philips; G B Baker; H R McKim
Journal:  Experientia       Date:  1980-02-15

5.  Differential aversive stimulus properties of beta-phenylethylamine and of d-amphetamine.

Authors:  A J Greenshaw; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 6.  Binding sites for brain trace amines.

Authors:  T V Nguyen; A V Juorio
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

7.  Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  T S Rao; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

8.  The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline.

Authors:  I A Paterson
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

9.  Determination of regional distributions of phenylethylamine and meta- and para-tyramine in rat brain regions and presence in human and dog plasma by an ultra-sensitive negative chemical ion gas chromatography-mass spectrometric (NCI-GC-MS) method.

Authors:  D A Durden; B A Davis
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

10.  A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.

Authors:  C T Dourish
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.